NHI· Real Estate› REIT - Healthcare Facilities

National Health Investors, Inc.

Stage 4 · Declining · week 6

As of Oct 22, 2026, National Health Investors is in Stage 4, the downtrend phase, now in week 6 (since Sep 16, 2026). It closed at $66.96, 23.6% below its 52-week high and below its 200-day average, which is falling.

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). More about the company

$66.96

+3.14% today

$3.3B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is NHI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 52w

S2 36w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 2w → S3 5w → S4 6w → S1 1w → S2 52w → S3 10w → S4 6w → S1 7w → S2 6w → S3 5w → S4 4w → S3 1w → S2 36w → S3 5w → S4 7w → S1 7w → S4 5w current

Total tracked: 165 weeks across 17 stage runs.

NHI among REIT - Healthcare Facilities15th of 17 by relative strength

All 17 →

Stocks in REIT - Healthcare Facilities ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	DHCDiversified Healthcare Trust	Stage 3 · wk 9	94	−3.1%
2	WELLWelltower Inc.	Stage 3 · wk 3	80	+3.3%
3	LTCLTC Properties, Inc.	Stage 2 · wk 14	77	+2.3%
4	AHRAmerican Healthcare REIT, Inc.	Stage 3 · wk 4	76	+3.8%
5	VTRVentas, Inc.	Stage 3 · wk 4	74	+1.0%
6	OHIOmega Healthcare Investors, Inc.	Stage 3 · wk 4	71	+0.3%
7	STRWStrawberry Fields REIT, Inc.	Stage 3 · wk 3	69	−6.0%
8	SBRASabra Health Care REIT, Inc.	Stage 3 · wk 3	66	−0.5%
…15	NHINational Health Investors, Inc.	Stage 4 · wk 6	49	+1.1%

vs 52W High

-23.6%

$63.96 lo$87.68 hi

23.6% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-10.6%

200 DMA: $74.90 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.68x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+1.1%

-15.7%

-11.4%

YTD

-9.6%

-6.0%

Scan Membership

Breakout Watch

Latest: 2025-05-05

9 appearances in last 60 days. First seen: 2018-12-11.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 0.68x

2026-10-21S4

Wk 6 · Vol 0.66x

2026-10-20S4

Wk 5 · Vol 0.77x

2026-10-19S4

Wk 5 · Vol 0.67x

2026-10-16S4

Wk 5 · Vol 0.58x

2026-10-15S4

Wk 5 · Vol 0.60x

2026-10-14S4

Wk 5 · Vol 0.50x

2026-10-13S4

Wk 4 · Vol 0.64x

2026-10-12S4

Wk 4 · Vol 0.67x

2026-10-09S4

Wk 4 · Vol 0.45x

2026-10-08S4

Wk 4 · Vol 1.07x

2026-10-07S4

Wk 4 · Vol 1.02x

Moving averages & range

50 DMA

$68.21

200 DMA

$74.90

52W High

$87.68

52W Low

$63.96

5D Low

$64.70

Resistance levels (recent highs)

20d High

$66.96

60d High

$75.57

120d High

$79.96

250d High

$87.68

Next resistance

+12.9%

to 60d High

P/E (TTM)

19.4

Forward 19.4

Earnings Growth (YoY)

+45.2%

Revenue +33.8%

ROE

+10.7%

Profit margin +38.3%

Dividend Yield

5.79%

P/B 2.1

National Health Investors: quick answers

What stage is National Health Investors in?

As of Oct 22, 2026, National Health Investors (NHI) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 16, 2026 and is in week 6. What the four stages mean

Is National Health Investors in an uptrend?

No. National Health Investors is in a Stage 4 downtrend. It trades 10.6% below its 200-day average, which is falling.

How far is National Health Investors from its 52-week high?

National Health Investors closed at $66.96 on Oct 22, 2026, 23.6% below its 52-week high of $87.68. Its 52-week low is $63.96.

How has National Health Investors performed over the past year?

As of Oct 22, 2026, National Health Investors is down 6.0% over the past year and down 9.6% so far in 2026.

Which sector and industry is National Health Investors in?

National Health Investors is in the REIT - Healthcare Facilities industry, part of the Real Estate sector.

About this companyReal Estate· REIT - Healthcare Facilities

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. National Health Investors, Inc. was established on October 15th, 1991, and was incorporated in 1991 in Maryland and is based in Murfreesboro, Tennessee.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.